IRIS PubliCatt
PubliCatt è il repository istituzionale ad accesso aperto dell'Università Cattolica del Sacro Cuore, dove gli utenti autorizzati afferenti all'Ateneo provvedono direttamente e autonomamente a depositare e a rendere visibili le proprie pubblicazioni, inserendo i dati descrittivi del documento stesso ("metadati", quali il titolo, autore, abstract, etc.) e, laddove possibile, il testo della pubblicazione stessa (full-text).
PubliCatt utilizza la piattaforma IRIS (Institutional Research Information System) sviluppata da CINECA.
EnglishBackground: Agomelatine modulates brain-derived neurotrophic factor expression via its interaction with melatonergic and serotonergic receptors and has shown promising results in terms of brain-derived neurotrophic factor increase in animal models. Methods: Twenty-seven patients were started on agomelatine (25 mg/d). Venous blood was collected and brain-derived neurotrophic factor serum levels were measured at baseline and after 2 and 8 weeks along with a clinical assessment, including Hamilton Depression Rating Scale and Snaith-Hamilton Pleasure Scale. Results: Brain-derived neurotrophic factor serum concentration increased after agomelatine treatment. Responders showed a significant increase in brain-derived neurotrophic factor levels after 2 weeks of agomelatine treatment; no difference was observed in nonresponders. Linear regression analysis showed that more prominent brain-derived neurotrophic factor level variation was associated with lower baseline BDNF levels and greater anhedonic features at baseline. Conclusions: Patients affected by depressive disorders showed an increase of brain-derived neurotrophic factor serum concentration after a 2-week treatment with agomelatine. The increase of brain-derived neurotrophic factor levels was found to be greater in patients with lower brain-derived neurotrophic factor levels and marked anhedonia at baseline.
Martinotti, G., Pettorruso, M., De Berardis, D., Varasano, P. A., Pressanti, G. L., De Remigis, V., Valchera, A., Ricci, V., Di Nicola, M., Janiri, L., Biggio, G., Di Giannantonio, M., Agomelatine increases BDNF serum levels in depressed patients in correlation with the improvement of depressive symptoms, <<INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY>>, 2016; 19 (5): pyw003-N/A. [doi:10.1093/ijnp/pyw003] [http://hdl.handle.net/10807/94655]
| Autori: | |
| Titolo: | Agomelatine increases BDNF serum levels in depressed patients in correlation with the improvement of depressive symptoms |
| Digital Object Identifier (DOI): | http://dx.doi.org/10.1093/ijnp/pyw003 |
| URL: | http://ijnp.oxfordjournals.org/ |
| Data di pubblicazione: | 2016 |
| Abstract: | Background: Agomelatine modulates brain-derived neurotrophic factor expression via its interaction with melatonergic and serotonergic receptors and has shown promising results in terms of brain-derived neurotrophic factor increase in animal models. Methods: Twenty-seven patients were started on agomelatine (25 mg/d). Venous blood was collected and brain-derived neurotrophic factor serum levels were measured at baseline and after 2 and 8 weeks along with a clinical assessment, including Hamilton Depression Rating Scale and Snaith-Hamilton Pleasure Scale. Results: Brain-derived neurotrophic factor serum concentration increased after agomelatine treatment. Responders showed a significant increase in brain-derived neurotrophic factor levels after 2 weeks of agomelatine treatment; no difference was observed in nonresponders. Linear regression analysis showed that more prominent brain-derived neurotrophic factor level variation was associated with lower baseline BDNF levels and greater anhedonic features at baseline. Conclusions: Patients affected by depressive disorders showed an increase of brain-derived neurotrophic factor serum concentration after a 2-week treatment with agomelatine. The increase of brain-derived neurotrophic factor levels was found to be greater in patients with lower brain-derived neurotrophic factor levels and marked anhedonia at baseline. |
| Lingua: | Inglese |
| Rivista: | |
| Citazione: | Martinotti, G., Pettorruso, M., De Berardis, D., Varasano, P. A., Pressanti, G. L., De Remigis, V., Valchera, A., Ricci, V., Di Nicola, M., Janiri, L., Biggio, G., Di Giannantonio, M., Agomelatine increases BDNF serum levels in depressed patients in correlation with the improvement of depressive symptoms, <<INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY>>, 2016; 19 (5): pyw003-N/A. [doi:10.1093/ijnp/pyw003] [http://hdl.handle.net/10807/94655] |
| Appare nelle tipologie: | Articolo in rivista, Nota a sentenza |
File in questo prodotto:
Copyright © 2020